Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.73 USD | -0.96% | +6.31% | -25.45% |
06-03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
06-03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
INTELLIA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.96% | +6.31% | -25.45% | -47.58% | +50.93% | 2.19B |
Technical Rankings Surperformance
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.
- Comparison Chart